Adrian Kee Keong TEO, Ph.D.
Principal Investigator, Stem Cells and Diabetes Laboratory, IMCB, A*STAR
Assistant Professor, Department of Biochemistry and Department of Medicine
Precision Medicine Translational Research Programme (TRP), NUS
28th Feb 2024, 9:00am - 11:00am GST
| Title: | Human pluripotent stem cells for studying diabetes and cell replacement therapy |
| Location | YAS Auditorium |
| Abstract: | Adrian obtained his B.Sc. (1st Class) from the National University of Singapore. He completed his Ph.D. on stem cell biology with Ludovic Vallier at the University of Cambridge, under an A*STAR Scholarship. Concurrently, he was also an Honorary Cambridge Commonwealth Trust Scholar. He then trained with Rohit Kulkarni at Joslin Diabetes Center, Harvard Medical School, as a Juvenile Diabetes Research Foundation fellow, on pancreatic islet biology and diabetes. Adrian is currently a Principal Investigator at the Institute of Molecular and Cell Biology, A*STAR, and an Assistant Professor at NUS Medicine, Singapore, using human pluripotent stem cells for disease modelling of diabetes. He is also a co-founder of BetaLife Pte Ltd focused on the use of stem cell therapy for diabetes patients. He is a member of the Oxbridge Society of Singapore, the International Society for Stem Cell Research and an EXCO member/Vice-Secretary of the Stem Cell Society Singapore. |
| Bio: | Adrian obtained his B.Sc. (1st Class) from the National University of Singapore. He completed his Ph.D. on stem cell biology with Ludovic Vallier at the University of Cambridge, under an A*STAR Scholarship. Concurrently, he was also an Honorary Cambridge Commonwealth Trust Scholar. He then trained with Rohit Kulkarni at Joslin Diabetes Center, Harvard Medical School, as a Juvenile Diabetes Research Foundation fellow, on pancreatic islet biology and diabetes. Adrian is currently a Principal Investigator at the Institute of Molecular and Cell Biology, A*STAR, and an Assistant Professor at NUS Medicine, Singapore, using human pluripotent stem cells for disease modelling of diabetes. He is also a co-founder of BetaLife Pte Ltd focused on the use of stem cell therapy for diabetes patients. He is a member of the Oxbridge Society of Singapore, the International Society for Stem Cell Research and an EXCO member/Vice-Secretary of the Stem Cell Society Singapore. |